In Vivo Biorthogonal Antibody Click for Dual Targeting and Augmented Efficacy in Cancer Treatment

Antibody-drug conjugates (ADCs) have emerged as promising therapeutics for cancer treatment; however, their effectiveness has been limited by single antigen targeting, potentially leading to resistance mechanisms triggered by tumor compensatory pathways or reduced expression of the target protein. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Panikar, Sandeep Surendra, Berry, Na-Keysha, Shmuel, Shayla, Keltee, Nai, Pereira, Patrícia M.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659283/
https://www.ncbi.nlm.nih.gov/pubmed/37986985
http://dx.doi.org/10.1101/2023.09.05.556426

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659283/
https://www.ncbi.nlm.nih.gov/pubmed/37986985
http://dx.doi.org/10.1101/2023.09.05.556426

Ejemplares similares